Literature DB >> 2506212

Insulin-like growth factor-I regulates aromatase activity in human granulosa and granulosa luteal cells.

G F Erickson1, V G Garzo, D A Magoffin.   

Abstract

The purpose of this research was to test the hypothesis that insulin-like growth factor-I (IGF-I) regulates estradiol (E2) synthesis in human granulosa and granulosa luteal cells. Cells from individual follicles from spontaneous and human menopausal gonadotropin/CG-stimulated cycles were cultured in serum-free medium containing androstenedione, IGF-I, FSH, and/or CG. At 2, 4, and 6 days, E2 in the medium was measured by RIA. In the granulosa experiments, control cells produced basal levels of E2 at 2 days, and the levels increased with increasing follicle size. Treatment with FSH stimulated E2 production (on the average, 5-fold), and the effect was dose dependent (ED50 = 5 ng/mL or 16 mIU/mL). Incubation with IGF-I alone caused increases in E2 production comparable to those caused by FSH, and the IGF-I effect was dose dependent (ED50 = 8 ng/mL). In most cases, coincubation with FSH and IGF-I augmented E2 levels more than either hormone alone, and at 4 and 6 days the interaction was synergistic. The data from dose-response experiments suggested that the basis of the synergy between FSH and IGF-I was a marked potentiation by either hormone (approximately 10-fold) in the potency of the complementary hormone to stimulate E2 production. In the experiments with granulosa luteal cells from spontaneous and in vitro fertilization preovulatory follicles, the controls synthesized very high levels of E2 spontaneously at 2 days; however, E2 production declined 700% at 4 days, and no E2 was produced by control cells at 6 days. Treatment with FSH, CG, or IGF-I did not cause a significant increase in the high basal levels of E2 at 2 days. During subsequent culture, however, all three hormones stimulated E2 production at 4 and 6 days, but the increases were modest and not sustained. In contrast, coincubation of granulosa luteal cells with FSH plus IGF-I or CG plus IGF-I dramatically enhanced E2 production at 4 and 6 days (on the average, 4-fold), and the effects were sustained throughout the culture period. (ABSTRACT TRUNCATED AT 400 WORDS)

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2506212     DOI: 10.1210/jcem-69-4-716

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  28 in total

Review 1.  Growth factors in the ovary.

Authors:  G Giordano; A Barreca; F Minuto
Journal:  J Endocrinol Invest       Date:  1992-10       Impact factor: 4.256

2.  Insulin-like growth factor-1 and insulin-like growth factor binding protein-1 and 3 in the follicular fluid of infertile patients submitted to in vitro fertilization.

Authors:  J S L Cunha-Filho; N A Lemos; F M Freitas; A C Facin; P E Gewher-Filho; E P Passos
Journal:  J Assist Reprod Genet       Date:  2005-05       Impact factor: 3.412

Review 3.  Growth hormone--a cogonadotropin? Its role in ovulation induction.

Authors:  Z Blumenfeld
Journal:  J In Vitro Fert Embryo Transf       Date:  1991-06

4.  Evidence that increased ovarian aromatase activity and expression account for higher estradiol levels in African American compared with Caucasian women.

Authors:  N D Shaw; S S Srouji; C K Welt; K H Cox; J H Fox; J M Adams; P M Sluss; J E Hall
Journal:  J Clin Endocrinol Metab       Date:  2013-11-27       Impact factor: 5.958

5.  The role of bone morphogenetic protein 6 in accumulation and regulation of neutrophils in the human ovary.

Authors:  Ikumi Akiyama; Osamu Yoshino; Yutaka Osuga; Jia Shi; Masashi Takamura; Miyuki Harada; Kaori Koga; Yasushi Hirota; Tetsuya Hirata; Tomoyuki Fujii; Shigeru Saito; Shiro Kozuma
Journal:  Reprod Sci       Date:  2014-01-09       Impact factor: 3.060

Review 6.  Growth hormone cotreatment with gonadotropins in ovulation induction.

Authors:  P G Artini; A A de Micheroux; G D'Ambrogio
Journal:  J Endocrinol Invest       Date:  1996-12       Impact factor: 4.256

Review 7.  Clinical utility of adjuvant growth hormone in the treatment of patients with polycystic ovaries undergoing in vitro fertilization.

Authors:  P G Artini; A A de Micheroux; F Taponeco; V Cela; G D'Ambrogio; A R Genazzani
Journal:  J Assist Reprod Genet       Date:  1997-01       Impact factor: 3.412

8.  IGF1R signaling is necessary for FSH-induced activation of AKT and differentiation of human Cumulus granulosa cells.

Authors:  Sarah C Baumgarten; Scott M Convissar; Michelle A Fierro; Nicola J Winston; Bert Scoccia; Carlos Stocco
Journal:  J Clin Endocrinol Metab       Date:  2014-05-21       Impact factor: 5.958

9.  GH-IGF-I axis in non-obese women with functional hyperandrogenism.

Authors:  M Legan; A Kocijancic; J Prezelj; J Osredkar; S Fisker
Journal:  J Endocrinol Invest       Date:  2002-09       Impact factor: 4.256

10.  IGF-I signaling is essential for FSH stimulation of AKT and steroidogenic genes in granulosa cells.

Authors:  Ping Zhou; Sarah C Baumgarten; Yanguang Wu; Jill Bennett; Nicola Winston; Jennifer Hirshfeld-Cytron; Carlos Stocco
Journal:  Mol Endocrinol       Date:  2013-01-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.